161 related articles for article (PubMed ID: 29893051)
81. Mouse models for actinic keratoses.
Choi J; West CE; Roh YS; Sutaria N; Kwatra SG; Kwatra MM
J Pharmacol Toxicol Methods; 2021; 110():107071. PubMed ID: 33933627
[TBL] [Abstract][Full Text] [Related]
82. Pharmacotherapy of actinic keratosis.
Berman B; Amini S; Valins W; Block S
Expert Opin Pharmacother; 2009 Dec; 10(18):3015-31. PubMed ID: 19925043
[TBL] [Abstract][Full Text] [Related]
83. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.
Neri L; Peris K; Longo C; Calvieri S; Frascione P; Parodi A; Eibenschuz L; Bottoni U; Pellacani G;
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):93-107. PubMed ID: 29920789
[TBL] [Abstract][Full Text] [Related]
84. Prevalence of actinic keratosis among dermatology outpatients in Spain.
Ferrándiz C; Plazas MJ; Sabaté M; Palomino R;
Actas Dermosifiliogr; 2016 Oct; 107(8):674-80. PubMed ID: 27445129
[TBL] [Abstract][Full Text] [Related]
85. Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma.
Schmitz L; Gambichler T; Gupta G; Stücker M; Dirschka T
J Eur Acad Dermatol Venereol; 2018 May; 32(5):752-756. PubMed ID: 29117441
[TBL] [Abstract][Full Text] [Related]
86. 5-fluorouracil chemowraps for the treatment of multiple actinic keratoses.
Peuvrel L; Saint-Jean M; Quereux G; Brocard A; Le Moigne M; Frénard C; Khammari A; Dreno B
Eur J Dermatol; 2017 Dec; 27(6):635-640. PubMed ID: 29311041
[TBL] [Abstract][Full Text] [Related]
87. Dermal epidermal junction detection for full-field optical coherence tomography data of human skin by deep learning.
Chou HY; Huang SL; Tjiu JW; Chen HH
Comput Med Imaging Graph; 2021 Jan; 87():101833. PubMed ID: 33338907
[TBL] [Abstract][Full Text] [Related]
88. Spatiotemporal closure of fractional laser-ablated channels imaged by optical coherence tomography and reflectance confocal microscopy.
Banzhaf CA; Wind BS; Mogensen M; Meesters AA; Paasch U; Wolkerstorfer A; Haedersdal M
Lasers Surg Med; 2016 Feb; 48(2):157-65. PubMed ID: 26266688
[TBL] [Abstract][Full Text] [Related]
89. Clinical, dermoscopic and immunohistochemical assessment of actinic keratoses and evaluation of the effectiveness of diclofenac therapy with immunohistochemical analysis.
Çayirli M; Köse O; Demiriz M
Arch Dermatol Res; 2013 Jul; 305(5):389-95. PubMed ID: 23397597
[TBL] [Abstract][Full Text] [Related]
90. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
[TBL] [Abstract][Full Text] [Related]
91. Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses.
Ulrich C; Johannsen A; Röwert-Huber J; Ulrich M; Sterry W; Stockfleth E
Eur J Dermatol; 2010; 20(4):482-8. PubMed ID: 20507841
[TBL] [Abstract][Full Text] [Related]
92. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses.
Jorizzo JL; Markowitz O; Lebwohl MG; Bourcier M; Kulp J; Meng TC; Levy S
J Drugs Dermatol; 2010 Sep; 9(9):1101-8. PubMed ID: 20865842
[TBL] [Abstract][Full Text] [Related]
93. Pharmacotherapy of actinic keratosis: an update.
Berman B; Amini S
Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
[TBL] [Abstract][Full Text] [Related]
94. Daylight Photodynamic Therapy for Actinic Keratoses.
Morton CA; Braathen LR
Am J Clin Dermatol; 2018 Oct; 19(5):647-656. PubMed ID: 29752702
[TBL] [Abstract][Full Text] [Related]
95. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin.
Fernández-Figueras MT; Carrato C; Sáenz X; Puig L; Musulen E; Ferrándiz C; Ariza A
J Eur Acad Dermatol Venereol; 2015 May; 29(5):991-7. PubMed ID: 25428612
[TBL] [Abstract][Full Text] [Related]
96. The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Kleinpenning MM; van de Kerkhof PC; Gerritsen RM
J Dermatolog Treat; 2010 Jul; 21(4):252-7. PubMed ID: 19832288
[TBL] [Abstract][Full Text] [Related]
97. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
98. Semi-automated localization of dermal epidermal junction in optical coherence tomography images of skin.
Taghavikhalilbad A; Adabi S; Clayton A; Soltanizadeh H; Mehregan D; Avanaki MRN
Appl Opt; 2017 Apr; 56(11):3116-3121. PubMed ID: 28414370
[TBL] [Abstract][Full Text] [Related]
99. Review ofactinic keratosis. Part I: etiology, epidemiology and clinical presentation.
Goldberg LH; Mamelak AJ
J Drugs Dermatol; 2010 Sep; 9(9):1125-32. PubMed ID: 20865846
[TBL] [Abstract][Full Text] [Related]
100. Treatment of facial actinic keratoses with a cream containing octatrienoic acid: a multicenter clinical experience.
Lombardi M; Rossi A; Fortuna MC; Garelli V; Sama E; Senis D; Costa C
G Ital Dermatol Venereol; 2018 Dec; 153(6):860-865. PubMed ID: 29963806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
